Hepatocellular carcinoma and liver transplantation

Orvosi hetilap
Imre Fehérvári

Abstract

In this review article author analyzes the results of liver transplantation in hepatocellular carcinoma. Due to the restrictive criteria, long term survival exceeds the results of surgical resections in many centers. With the use of biomarker des-carboxy-prothrombin, Asian transplant centers have significantly modified the previous restrictions. Author overviews the possible therapies of patients on the waiting list, as well as bridging and down staging modalities.

References

Mar 14, 1996·The New England Journal of Medicine·V MazzaferroL Gennari
Aug 30, 2002·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Francis Y YaoJohn P Roberts
Oct 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hwan Y YooPaul J Thuluvath
Sep 18, 2007·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·F Y YaoJ P Roberts
Nov 30, 2007·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Takashi ItoShinji Uemoto
Aug 19, 2008·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Emily C BellavanceTimothy M Pawlik
Oct 15, 2008·Gastroenterology·Bilal Hameed, John R Lake

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.